FDA Inspection 1273245 — Freilich, Dr Bradley
The FDA completed an inspection of Freilich, Dr Bradley on June 5, 2025 in Kansas City, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 5, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Kansas City, MO (United States)
Additional Details
Clinical Investigator (CI)